Detalhe da pesquisa
1.
Photodynamic cystoscopy for bladder cancer diagnosis and for NMIBC follow-up: An overview of systematic reviews and meta-analyses.
Prog Urol
; 33(6): 307-318, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37088584
2.
Administration of neoadjuvant chemotherapy for muscle-invasive bladder cancer in real life: Are urologists still too cautious?
Prog Urol
; 31(6): 332-339, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33468415
3.
Variation in neutrophil to lymphocyte ratio (NLR) as predictor of outcomes in metastatic renal cell carcinoma (mRCC) and non-small cell lung cancer (mNSCLC) patients treated with nivolumab.
Cancer Immunol Immunother
; 69(12): 2513-2522, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32561968
4.
Apalutamide and overall survival in non-metastatic castration-resistant prostate cancer.
Ann Oncol
; 30(11): 1813-1820, 2019 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31560066
5.
Controversies and consensus in the innovation access for cancer therapy in the European countries: on the subject of metastatic prostate cancer.
Ann Oncol
; 28(2): 421-426, 2017 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28426107
6.
Biological toxicities as surrogate markers of efficacy in patients treated with mTOR inhibitors for metastatic renal cell carcinoma.
BMC Cancer
; 17(1): 27, 2017 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28061764
7.
Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors.
Br J Dermatol
; 176(6): 1649-1652, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27943234
8.
mTOR-inhibitor treatment of metastatic renal cell carcinoma: contribution of Choi and modified Choi criteria assessed in 2D or 3D to evaluate tumor response.
Eur Radiol
; 26(1): 278-85, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25953002
9.
[Castration modalities in prostate cancer: Are they all equal?]. / Modalités de castration dans la prise en charge du cancer de la prostate: sont-elles toutes équivalentes ?
Prog Urol
; 26(5): 319-28, 2016 Apr.
Artigo
em Francês
| MEDLINE | ID: mdl-27017327
10.
RANK/OPG ratio of expression in primary clear-cell renal cell carcinoma is associated with bone metastasis and prognosis in patients treated with anti-VEGFR-TKIs.
Br J Cancer
; 113(9): 1313-22, 2015 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26528707
11.
Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma.
Br J Cancer
; 113(1): 12-9, 2015 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-26086878
12.
Bone health in cancer: ESMO Clinical Practice Guidelines.
Ann Oncol
; 31(12): 1650-1663, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32801018
13.
First-line treatment with sunitinib for type 1 and type 2 locally advanced or metastatic papillary renal cell carcinoma: a phase II study (SUPAP) by the French Genitourinary Group (GETUG).
Ann Oncol
; 26(6): 1123-1128, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25802238
14.
Outcomes from second-line therapy in long-term responders to first-line tyrosine kinase inhibitor in clear-cell metastatic renal cell carcinoma.
Ann Oncol
; 26(2): 378-85, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25467013
15.
Nivolumab immunotherapy rechallenge for progressive laryngeal squamous cell carcinoma after failure of conventional treatment: A CARE case report.
Eur Ann Otorhinolaryngol Head Neck Dis
; 2024 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38418356
16.
Development and validation of a prognostic model in patients with metastatic renal cell carcinoma treated with sunitinib: a European collaboration.
Br J Cancer
; 109(2): 332-41, 2013 Jul 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-23807171
17.
Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib.
Br J Cancer
; 108(4): 887-900, 2013 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-23462807
18.
Triple combination of bevacizumab, gemcitabine and platinum salt in metastatic collecting duct carcinoma.
Ann Oncol
; 24(12): 2963-7, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24190963
19.
Impact of cabazitaxel on 2-year survival and palliation of tumour-related pain in men with metastatic castration-resistant prostate cancer treated in the TROPIC trial.
Ann Oncol
; 24(9): 2402-8, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23723295
20.
Circulating Biomarkers in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma Treated With Everolimus in the Pre-nephrectomy Setting.
Clin Oncol (R Coll Radiol)
; 35(3): e245-e255, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36526521